Skip to main content

Table 1 Genotype and allele distribution of variants in the ARLTS1 gene in BCC cases and controls

From: ARLTS1 polymorphisms and basal cell carcinoma of the skin

Genotype/Allele

Cases*

Controls

OR (95%CI)

P-value

S99S (297G>A)

    

   GG

487 (92.2)

490 (91.9)

1.0 (referent)

 

   GA

41 (7.7)

43 (8.1)

1.1 (0.7-1.7)

0.81**

   G-allele

1015 (96.1)

1023 (96.0)

1.0 (referent)

 

   A-allele

41 (3.9)

43 (4.0)

1.1 (0.7-1.6)

0.81

P131L (392C>T)

    

   CC

496 (93.9)

508 (95.3)

1.0 (referent)

 

   CT

32 (6.1)

25 (4.7)

1.3 (0.8-2.3)

0.30

   C-allele

1024 (97.0)

1041 (97.7)

1.0 (referent)

 

   T-allele

32 (3.0)

25 (2.3)

1.3 (0.8-2.3)

0.31

L132L (396G>C)

    

   GG

527 (99.8)

531 (99.6)

1.0 (referent)

 

   GC

1 (0.2)

2 (0.4)

0.4 (0.1-4.0)

0.40

   G-allele

1055 (99.9)

1064 (99.8)

1.0 (referent)

 

   C-allele

1 (0.1)

2 (0.2)

0.4 (0.1-4.0)

0.40

C148R (442T>C)

    

   TT

165 (31.3)

155 (29.1)

1.0 (referent)

 

   TC

250 (47.4)

258 (48.4)

0.9 (0.7-1.2)

 

   CC

113 (21.0)

120 (22.5)

0.9 (0.6-1.2)

0.64

   T-allele

580 (54.9)

568 (53.3)

1.0 (referent)

 

   C-allele

476 (45.1)

498 (46.7)

0.9 (0.8-1.1)

0.36

W149X (446G>A)

    

   GG

519 (98.3)

524 (98.3)

1.0 (referent)

 

   GA

9 (1.7)

9 (1.7)

1.5 (0.6-4.0)

0.41

   G-allele

1047 (99.2)

1057 (99.2)

1.0 (referent)

 

   A-allele

9 (0.8)

9 (0.8)

1.5 (0.5-3.5)

0.41

  1. *The number of cases and controls included in the study was 529 and 533, respectively. The sequencing for genotyping failed for one sample among cases.
  2. **Global P-values calculated from chi^2 test for genotype as a single event and allele effects were adjusted for age, gender and nationality.